Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Transdermal Skin Patches Market: By Product, By Application, By Distribution Channel and Geography
Transdermal Skin Patches Market: By Product, By Application, By Distribution Channel and Geography
Transdermal Skin Patches Market was valued at US$ 7,244.34 million in 2022 and is expected to grow at US$ 9,572.35 million by 2028 recording a significant CAGR of 4.79% from 2023-2029. Transdermal skin patches are the adhesive patches which contain medicaments, placed on the skin and delivers the specific dosage of medication into the blood stream through the skin. Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period. In Febrauary 2015, China National Bluestar (Group) Co, Ltd. has launched Silbone soft silicone adhesive for skin application including transdermal patches.
Study Period
2024-2030Base Year
2023CAGR
4.79%Largest Market
North AmericaFastest Growing Market
Europe
Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period.
Geographically, global transdermal skin patches market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is expected to have significant growth in the market owing to the uprising of the technologies to advancement the transdermal skin patches and presence of the key market players in the region. Europe market projected to grow at notable rates owing the adoption of cutting edge technologies and state of art infrastructure and acceptance of the new technological innovations. Asia Pacific market expected to have the significant growth rate during the forecast period due to the developing healthcare infrastructure and expansion of multinational companies into the emerging Asian countries such as India and China.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 7,244.34 million |
|
Market Size in 2028 |
US$ 9,572.35 million |
|
Market CAGR |
4.79% |
|
By Product |
|
|
By Application |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The key segments covered in the Transdermal Skin Patches Market are technology, components, application, and end-users.
The Transdermal Skin Patches Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Transdermal Skin Patches Market key players Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc., 3M Company, Accrux Ltd., Access Pharmaceuticals Inc.
| 1.Executive Summary |
| 2.Global Transdermal Skin Patches Market Introduction |
| 2.1.Global Transdermal Skin Patches Market - Taxonomy |
| 2.2.Global Transdermal Skin Patches Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Transdermal Skin Patches Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Transdermal Skin Patches Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Transdermal Skin Patches Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Reservoir |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Drug in Adhesive |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Multilaminate |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Matrix |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Transdermal Skin Patches Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hormone Replacement |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pain Relief |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Motion Sickness |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Nicotine Cessation |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Neurological Disorder |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Cardiovascular Disorders |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Transdermal Skin Patches Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospital Pharmacies |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Retail Pharmacies |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Transdermal Skin Patches Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Reservoir |
| 9.1.2.Drug in Adhesive |
| 9.1.3.Multilaminate |
| 9.1.4.Matrix |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hormone Replacement |
| 9.2.2.Pain Relief |
| 9.2.3.Motion Sickness |
| 9.2.4.Nicotine Cessation |
| 9.2.5.Neurological Disorder |
| 9.2.6.Cardiovascular Disorders |
| 9.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital Pharmacies |
| 9.3.2.Retail Pharmacies |
| 9.3.3.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Reservoir |
| 10.1.2.Drug in Adhesive |
| 10.1.3.Multilaminate |
| 10.1.4.Matrix |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hormone Replacement |
| 10.2.2.Pain Relief |
| 10.2.3.Motion Sickness |
| 10.2.4.Nicotine Cessation |
| 10.2.5.Neurological Disorder |
| 10.2.6.Cardiovascular Disorders |
| 10.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital Pharmacies |
| 10.3.2.Retail Pharmacies |
| 10.3.3.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Reservoir |
| 11.1.2.Drug in Adhesive |
| 11.1.3.Multilaminate |
| 11.1.4.Matrix |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hormone Replacement |
| 11.2.2.Pain Relief |
| 11.2.3.Motion Sickness |
| 11.2.4.Nicotine Cessation |
| 11.2.5.Neurological Disorder |
| 11.2.6.Cardiovascular Disorders |
| 11.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital Pharmacies |
| 11.3.2.Retail Pharmacies |
| 11.3.3.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Reservoir |
| 12.1.2.Drug in Adhesive |
| 12.1.3.Multilaminate |
| 12.1.4.Matrix |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hormone Replacement |
| 12.2.2.Pain Relief |
| 12.2.3.Motion Sickness |
| 12.2.4.Nicotine Cessation |
| 12.2.5.Neurological Disorder |
| 12.2.6.Cardiovascular Disorders |
| 12.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital Pharmacies |
| 12.3.2.Retail Pharmacies |
| 12.3.3.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Reservoir |
| 13.1.2.Drug in Adhesive |
| 13.1.3.Multilaminate |
| 13.1.4.Matrix |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Hormone Replacement |
| 13.2.2.Pain Relief |
| 13.2.3.Motion Sickness |
| 13.2.4.Nicotine Cessation |
| 13.2.5.Neurological Disorder |
| 13.2.6.Cardiovascular Disorders |
| 13.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital Pharmacies |
| 13.3.2.Retail Pharmacies |
| 13.3.3.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Teva Pharmaceutical Industries Ltd. |
| 14.2.2.Mylan Pharmaceuticals Inc. |
| 14.2.3.3M Company |
| 14.2.4.Accrux Ltd. |
| 14.2.5.Access Pharmaceuticals Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.